Updates are available Correction dated 2023-08-02
Click to view Correction: https://doi.org/10.1007/s00508-023-02251-y
-
Authors
Gartlehner, Gerald
Schernhammer, Eva
Lax, Sigurd F.
Preusser, Matthias
Bachler, Herbert
Titzer, Harald
Kletecka-Pulker, Maria
Turnher, Helga
Siebert, Uwe
-
Funding
Funding for this research was provided by:
Danube University Krems University for Continuing Education
- License Information
-
More Information
Article History
Received: 15 April 2023
Accepted: 18 April 2023
First Online: 31 May 2023
Change Date: 2 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00508-023-02251-y
Conflict of interest
: G. Gartlehner, E. Schernhammer, S.F. Lax, H. Bachler, H. Titzer, M. Kletecka-Pulker and H. Turnher declare that they have no competing interests. M. Preusser has received honoraria for lectures, consultation, or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra, Gan & Lee Pharmaceuticals, Servier. U. Siebert declares that he is a member of the Oncology Advisory Council of the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection, a member of the European Commission Initiative on Colorectal Cancer (ECICC) Expert Pool, and Co-Chair of the international SMDM Modeling Good Research Practices Task Force.
